CL2021002911A1 - Composiciones farmacéuticas de combinación a dosis fijas de liberación inmediata, métodos y usos de las mismas - Google Patents

Composiciones farmacéuticas de combinación a dosis fijas de liberación inmediata, métodos y usos de las mismas

Info

Publication number
CL2021002911A1
CL2021002911A1 CL2021002911A CL2021002911A CL2021002911A1 CL 2021002911 A1 CL2021002911 A1 CL 2021002911A1 CL 2021002911 A CL2021002911 A CL 2021002911A CL 2021002911 A CL2021002911 A CL 2021002911A CL 2021002911 A1 CL2021002911 A1 CL 2021002911A1
Authority
CL
Chile
Prior art keywords
dose combination
methods
pharmaceutical compositions
immediate release
fixed dose
Prior art date
Application number
CL2021002911A
Other languages
English (en)
Inventor
Serra João Pedro Silva
Machuco Estevens Maria Catarina Oliveira
Marques Da Costa Ricardo Manuel Silva
Filipe Augusto Eugénio Pardal
Original Assignee
Tecnimede Sociedade Tecnico Medicinal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=71092565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2021002911(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tecnimede Sociedade Tecnico Medicinal Sa filed Critical Tecnimede Sociedade Tecnico Medicinal Sa
Publication of CL2021002911A1 publication Critical patent/CL2021002911A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente divulgación se refiere a una composición farmacéutica de combinación a dosis fijas de liberación inmediata que comprende los principios activos farmacéuticos memantina y donepezilo para el tratamiento de la enfermedad de Alzheimer de moderada a grave.
CL2021002911A 2019-05-31 2021-11-04 Composiciones farmacéuticas de combinación a dosis fijas de liberación inmediata, métodos y usos de las mismas CL2021002911A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT11555719 2019-05-31

Publications (1)

Publication Number Publication Date
CL2021002911A1 true CL2021002911A1 (es) 2022-07-15

Family

ID=71092565

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2021002911A CL2021002911A1 (es) 2019-05-31 2021-11-04 Composiciones farmacéuticas de combinación a dosis fijas de liberación inmediata, métodos y usos de las mismas

Country Status (15)

Country Link
EP (2) EP4238555A3 (es)
BR (1) BR112021024054A2 (es)
CL (1) CL2021002911A1 (es)
CO (1) CO2021014967A2 (es)
DK (1) DK3843702T3 (es)
FI (1) FI3843702T3 (es)
HR (1) HRP20231200T1 (es)
IL (1) IL288505A (es)
MX (2) MX2021014673A (es)
PE (1) PE20220936A1 (es)
PT (1) PT3843702T (es)
SA (1) SA521430969B1 (es)
SI (1) SI3843702T1 (es)
WO (1) WO2020240505A1 (es)
ZA (2) ZA202110478B (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
ES2059602T3 (es) 1989-04-14 1994-11-16 Merz & Co Gmbh & Co Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral.
WO1997046526A1 (en) 1996-06-07 1997-12-11 Eisai Co., Ltd. Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
PT1509232E (pt) 2002-05-31 2009-01-07 Lundbeck & Co As H Uma combinação de um antagonista de nmda e inibidores da acetilcolina esterase para o tratamento da doença de alzheimer
TW200418446A (en) 2002-10-24 2004-10-01 Merz Pharma Gmbh & Co Kgaa Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
JP5025468B2 (ja) * 2004-06-17 2012-09-12 メルツ・ファルマ・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト・アウフ・アクティーン メマンチン又はネラメキサンの直接圧縮によって製造された、飲用に適した即効型錠剤
WO2006076562A1 (en) 2005-01-11 2006-07-20 Teva Pharmaceutical Fine Chemicals S.R.L. Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride
ATE481096T1 (de) 2005-04-06 2010-10-15 Adamas Pharmaceuticals Inc Verfahren und zusammensetzungen zur behandlung von zns-erkrankungen
CN101166543B (zh) * 2005-04-28 2014-07-16 卫材R&D管理有限公司 含抗痴呆药物的组合物
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
CN105816441A (zh) * 2016-05-31 2016-08-03 北京康立生医药技术开发有限公司 盐酸美金刚多奈哌齐复方制剂
KR101938872B1 (ko) * 2016-09-30 2019-01-16 주식회사 바이오파마티스 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법
WO2018062941A1 (ko) * 2016-09-30 2018-04-05 주식회사 바이오파마티스 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법

Also Published As

Publication number Publication date
MX2025002148A (es) 2025-04-02
MX2021014673A (es) 2022-01-11
DK3843702T3 (da) 2023-10-09
HRP20231200T1 (hr) 2024-01-19
BR112021024054A2 (pt) 2022-01-11
EP4238555A2 (en) 2023-09-06
IL288505A (en) 2022-01-01
CO2021014967A2 (es) 2021-11-19
PE20220936A1 (es) 2022-05-31
FI3843702T3 (fi) 2023-10-09
SA521430969B1 (ar) 2023-12-05
ZA202311560B (en) 2024-07-31
EP3843702A1 (en) 2021-07-07
EP4238555A3 (en) 2023-09-20
SI3843702T1 (sl) 2023-12-29
EP3843702B1 (en) 2023-07-05
ZA202110478B (en) 2024-08-28
WO2020240505A1 (en) 2020-12-03
PT3843702T (pt) 2023-10-13

Similar Documents

Publication Publication Date Title
ECSP21051833A (es) Combinación de dextrometorfano y bupropión para el tratamiento de depresión
CL2020000747A1 (es) Formulaciones de niraparib.
CL2022002564A1 (es) Combinaciones de brimonidina de dosis baja y usos de las mismas. (solicitud divisional de 201903572)
AR081774A1 (es) Composiciones farmaceuticas de co-cristales de tramadol y coxibs
UY31747A (es) Nuevas formulaciones, comprimidos que comprenden tales formulaciones, su uso y procedimiento para su preparacion
ECSP066990A (es) Formulaciones con liberación controlada de principio activo que contienen vardenafilo
AR120057A1 (es) Composiciones neoantigénicas y usos de estas
CL2019002172A1 (es) Agente terapéutico para enfermedades del hígado.
PA8616201A1 (es) Composiciones farmaceuticas de liberacion sostenida
MX2016010179A (es) Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer.
CL2011002766A1 (es) Compuestos derivados de carboxamida, inhibidores de calpaina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades neurodegenerativas, alzahimer, dolor, entre otras.
PE20151607A1 (es) Formulaciones de compuestos organicos
UY32109A (es) Métodos para utilizar composiciones de liberación sostenida de aminopiridina
AR073265A1 (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
CL2021002107A1 (es) Triamtereno o nolatrexed para uso en el tratamiento de fenilcetonuria.
ES2129448T3 (es) Uso de 2-(2-nitro-4-trifluorometilbenzoil)-1,3-ciclohexanodiona en el tratamiento de tirosinemia y composiciones farmaceuticas.
PE20251582A1 (es) Composicion biocida
JP2025507472A5 (es)
PA8549401A1 (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido
CO2021014967A2 (es) Composiciones farmacéuticas de combinación a dosis fijas de liberación inmediata, métodos y usos de las mismas
MX2022005388A (es) Compuestos de pirrolidina y piperidina.
AR114074A1 (es) Combinación farmacéutica que comprende tramadol clorhidrato de liberación extendida y etoricoxib de liberación inmediata, y su uso para el tratamiento del dolor
UY37413A (es) Formulaciones de liberación inmediata de oprozomib
CO2022011987A2 (es) Usos y composiciones a base de polifenoles para mejorar la biodisponibilidad oral del hidroxitirol
CL2022000095A1 (es) Composiciones farmacéuticas resistentes a la descarga de dosis que comprenden venirunad